Pharmacological research in pediatrics: From neonates to adolescents

• Published in: Advanced drug delivery reviews Vol. 58; no. 1; pp. 4 - 14
• Main Authors: Rakhmanina, Natella Y., van den Anker, John N.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 20.04.2006
• Subjects: Adolescent; Child; Child, Preschool; Drug Labeling; Drug metabolism in pediatrics; Drug Prescriptions - standards; Drug therapy in pediatrics; Humans; Infant; Infant, Newborn; Off-label prescriptions; Pediatrics; Pharmaceutical Preparations - administration & dosage; Pharmaceutical Preparations - metabolism; Phase I enzymes; Phase II enzymes; Drug metabolism in pediatrics; Off-label prescriptions; Drug therapy in pediatrics; Phase I enzymes; Phase II enzymes
• ISSN: 0169-409X; 1872-8294
• DOI: 10.1016/j.addr.2005.12.001

The data guiding the dosing, efficacy and safety of medicines for children have lagged substantially as compared to the information available for adults. As a consequence, pediatricians faced with the prospect of confining their practice to medicines with adequate information have frequently resorted to prescribing medicines for unapproved uses (different dose, frequency, age group, route, indication or formulation). Although a long time in coming, the past decade, have witnessed a new era in drug development for children — an era that is still in its infancy, but which is currently showing signs of maturation. This review will give some of the history and current progress in pharmacological research and pediatric drug development.